Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Refining a Multifaceted Model of Perceived Utility of Genomic Sequencing Results. | Public Health Genomics | 2023 | 37607497 | PubTator, text mining | PubMed |
| Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. | Mol Oncol | 2023 | 37584393 | PubTator, text mining | PubMed |
| Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors. | Curr Pharm Des | 2023 | 37584353 | PubTator, text mining | PubMed |
The RNA-binding protein KSRP aggravates malignant progression of clear cell renal cell carcinoma through transcriptional inhibition and post-transcriptional destabilization of the NEDD4L ubiquitin ligase. | J Biomed Sci | 2023 | 37580757 | PubTator, text mining | PubMed |
| Epigenetic methylation changes: implication as biomarkers in oral and maxillofacial area cancers. | Med Pharm Rep | 2023 | 37577021 | PubTator, text mining | PubMed |
| Racial disparity in the genomics of precision oncology of prostate cancer. | Cancer Rep (Hoboken) | 2023 | 37565547 | PubTator, text mining | PubMed |
| Integrated analysis of human DNA methylation, gene expression, and genomic variation in iMETHYL database using kernel tensor decomposition-based unsupervised feature extraction. | PLoS One | 2023 | 37556429 | PubTator, text mining | PubMed |
| Synthetic lethal approaches to target cancers with loss of PTEN function. | Genes Dis | 2023 | 37533462 | PubTator, text mining | PubMed |
| ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1. | Sci Rep | 2023 | 37524814 | PubTator, text mining | PubMed |
| Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation. | Front Immunol | 2023 | 37483631 | PubTator, text mining | PubMed |
| Mislocalization of pathogenic RBM20 variants in dilated cardiomyopathy is caused by loss-of-interaction with Transportin-3. | Nat Commun | 2023 | 37463913 | PubTator, text mining | PubMed |
| Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer. | Nat Commun | 2023 | 37463901 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
| Targeting Prostate Cancer, the 'Tousled Way'. | Int J Mol Sci | 2023 | 37446279 | PubTator, text mining | PubMed |
| Generation of a Well-Characterized Homozygous Chromodomain-Helicase-DNA-Binding Protein 4G1003D Mutant hESC Line Using CRISPR/eCas9 (ULIEGEe001-A-1). | Int J Mol Sci | 2023 | 37445725 | PubTator, text mining | PubMed |
| Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities. | Cancers (Basel) | 2023 | 37444571 | PubTator, text mining | PubMed |
| Engineering prostate cancer in vitro: what does it take? | Oncogene | 2023 | 37438470 | PubTator, text mining | PubMed |
| The role of DNA methylation in human pancreatic neuroendocrine tumours. | Endocr Oncol | 2023 | 37434653 | PubTator, text mining | PubMed |
| Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer. | Biol Direct | 2023 | 37434219 | PubTator, text mining | PubMed |
Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer. | PLoS One | 2023 | 37428725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=9